Check-Cap Ltd. (CHEK)
Stock Price:
$0.590 USD
-0.030 (-4.84%)
Updated Aug 11, 2020 4:00 PM EDT - Market closed
After-hours: $0.586 -0.005 (-0.76%) Aug 11, 7:55 PM
Key Info
| Market Cap |
17.80M |
| Revenue (ttm) |
n/a |
| Net Income (ttm) |
-13.84M |
| Shares Out |
46.23M |
| EPS (ttm) |
-1.09 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 11, 2020 |
| Last Price |
$0.590 |
| Previous Close |
$0.620 |
| Change ($) |
-0.030 |
| Change (%) |
-4.84% |
| Day's Open |
0.620 |
| Day's Range |
0.590 - 0.620 |
| Day's Volume |
3,360,063 |
| 52-Week Range |
0.440 - 2.370 |
More Stats
| Market Cap |
17.80M |
| Enterprise Value |
10.20M |
| Earnings Date (est) |
Nov 9, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
46.23M |
| Float |
27.86M |
| EPS (basic) |
-1.73 |
| EPS (diluted) |
-1.09 |
| FCF / Share |
-1.63 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
730,325 |
| Short Ratio |
0.23 |
| Short % of Float |
2.14% |
| Beta |
0.46 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
n/a |
| PB Ratio |
3.80 |
| Revenue |
n/a |
| Operating Income |
-14.07M |
| Net Income |
-13.84M |
| Free Cash Flow |
-13.01M |
| Net Cash |
7.60M |
| Net Cash / Share |
0.25 |
| Gross Margin |
n/a |
| Operating Margin |
n/a |
| Profit Margin |
n/a |
| FCF Margin |
n/a |
| ROA |
-50.92% |
| ROE |
-96.40% |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (2)
| Buy |
2 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$2.50*
(323.73% upside)
Low
2.00
Current: $0.590
High
3.00
Target: 2.50
*Average 12-month price target from 2 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|
| Revenue | - | - | - | - | - | - | - | - |
| Operating Income | -14.07 | -11.06 | -10.00 | -9.06 | -12.46 | -4.54 | -3.98 | -3.91 |
| Net Income | -13.84 | -10.59 | -9.77 | -8.83 | -12.29 | -0.61 | -3.37 | -3.72 |
| Shares Outstanding | 7.99 | 4.06 | 1.45 | 1.21 | 0.99 | 0.18 | 0.14 | 0.14 |
| Earnings Per Share | -1.73 | -2.61 | -6.72 | -7.31 | -12.67 | -14.16 | -39.24 | -41.88 |
| Operating Cash Flow | -12.84 | -10.11 | -8.99 | -7.92 | -8.63 | -3.86 | -3.01 | -4.16 |
| Capital Expenditures | -0.17 | -0.09 | -0.23 | -0.17 | -0.27 | -0.05 | -0.05 | -0.09 |
| Free Cash Flow | -13.01 | -10.21 | -9.22 | -8.09 | -8.90 | -3.90 | -3.06 | -4.25 |
| Cash & Equivalents | 8.04 | 14.57 | 7.00 | 11.64 | 14.25 | 1.12 | 4.98 | 8.03 |
| Total Debt | 0.43 | - | - | - | - | - | 0.59 | 0.53 |
| Net Cash / Debt | 7.60 | 14.57 | 7.00 | 11.64 | 14.25 | 1.12 | 4.39 | 7.50 |
| Assets | 9.43 | 15.44 | 7.91 | 12.30 | 15.30 | 2.99 | 5.38 | 8.50 |
| Liabilities | 3.20 | 2.41 | 2.00 | 1.89 | 2.65 | 3.81 | 4.18 | 3.37 |
| Book Value | 6.23 | 13.03 | 5.91 | 10.41 | 12.65 | -0.83 | 1.19 | 5.13 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Check-Cap Ltd. |
| Country |
Israel |
| Employees |
64 |
| CEO |
Alex Ovadia |
Stock Information
| Ticker Symbol |
CHEK |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Diagnostics & Research |
| Unique Identifier |
NASDAQ: CHEK |
| IPO Date |
February 19, 2015 |
Description
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays for screening of the colon to detect polyps, masses, and colorectal cancers in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a biocompatible unit worn on the patient's back for capsule control, tracking, and data recording; and C-Scan View, a personal computer-based software package, which is designed to retrieve and process clinical data from the C-Scan Track, and to reconstruct and produce 3D visualization of the colon's inner surface. The company was founded in 2004 and is based in Isfiya, Israel.